Yours, mine, or ours: Cautions about LRT

Wendy Elizabeth Bonython, Bruce Baer Arnold

Research output: Contribution to journalComment/debateResearchpeer-review

1 Citation (Scopus)

Abstract

[Extract] We appreciate the opportunity to present some further thoughts on the libertarian right to test initially proposed by Loi, and hope these additional comments will further inform debate about this critical emerging technology. Loi’s important argument is that individuals possess a prima facie libertarian right to test their genomes and that regulatory intervention restricting genetic testing must be justified by those proposing regulation. Our position is that the onus of justifying regulation is reversed. The risk to others whose genomic information is shared with the individual is potentially significant enough to warrant prima facie regulatory intervention, including protection against misuse of genetic information derived from those tests, not just against the individual tested but also against those who for reasons of common familial ancestry are also susceptible to misuse. Testing an individual’s genome does not merely reveal information about that individual; it reveals, or renders reasonably inferable, information about the genomes of close relatives due to the commonality of genomic DNA within families.
Original languageEnglish
Pages (from-to)791-792
Number of pages2
JournalJournal of Medical Ethics
Volume44
Issue number11
DOIs
Publication statusPublished - 1 Nov 2018
Externally publishedYes

Fingerprint

Genome
Genetic Testing
regulation
Technology
DNA
Testing
Ancestry
Render
Emerging Technologies
Warrants
Familial
Genetic Information

Cite this

Bonython, Wendy Elizabeth ; Arnold, Bruce Baer. / Yours, mine, or ours : Cautions about LRT. In: Journal of Medical Ethics. 2018 ; Vol. 44, No. 11. pp. 791-792.
@article{1be96d30cb1e4208ac238eca63d05167,
title = "Yours, mine, or ours: Cautions about LRT",
abstract = "[Extract] We appreciate the opportunity to present some further thoughts on the libertarian right to test initially proposed by Loi, and hope these additional comments will further inform debate about this critical emerging technology. Loi’s important argument is that individuals possess a prima facie libertarian right to test their genomes and that regulatory intervention restricting genetic testing must be justified by those proposing regulation. Our position is that the onus of justifying regulation is reversed. The risk to others whose genomic information is shared with the individual is potentially significant enough to warrant prima facie regulatory intervention, including protection against misuse of genetic information derived from those tests, not just against the individual tested but also against those who for reasons of common familial ancestry are also susceptible to misuse. Testing an individual’s genome does not merely reveal information about that individual; it reveals, or renders reasonably inferable, information about the genomes of close relatives due to the commonality of genomic DNA within families.",
author = "Bonython, {Wendy Elizabeth} and Arnold, {Bruce Baer}",
year = "2018",
month = "11",
day = "1",
doi = "10.1136/medethics-2017-104445",
language = "English",
volume = "44",
pages = "791--792",
journal = "Journal of Medical Ethics",
issn = "0306-6800",
publisher = "BMJ Publishing Group",
number = "11",

}

Yours, mine, or ours : Cautions about LRT. / Bonython, Wendy Elizabeth; Arnold, Bruce Baer.

In: Journal of Medical Ethics, Vol. 44, No. 11, 01.11.2018, p. 791-792.

Research output: Contribution to journalComment/debateResearchpeer-review

TY - JOUR

T1 - Yours, mine, or ours

T2 - Cautions about LRT

AU - Bonython, Wendy Elizabeth

AU - Arnold, Bruce Baer

PY - 2018/11/1

Y1 - 2018/11/1

N2 - [Extract] We appreciate the opportunity to present some further thoughts on the libertarian right to test initially proposed by Loi, and hope these additional comments will further inform debate about this critical emerging technology. Loi’s important argument is that individuals possess a prima facie libertarian right to test their genomes and that regulatory intervention restricting genetic testing must be justified by those proposing regulation. Our position is that the onus of justifying regulation is reversed. The risk to others whose genomic information is shared with the individual is potentially significant enough to warrant prima facie regulatory intervention, including protection against misuse of genetic information derived from those tests, not just against the individual tested but also against those who for reasons of common familial ancestry are also susceptible to misuse. Testing an individual’s genome does not merely reveal information about that individual; it reveals, or renders reasonably inferable, information about the genomes of close relatives due to the commonality of genomic DNA within families.

AB - [Extract] We appreciate the opportunity to present some further thoughts on the libertarian right to test initially proposed by Loi, and hope these additional comments will further inform debate about this critical emerging technology. Loi’s important argument is that individuals possess a prima facie libertarian right to test their genomes and that regulatory intervention restricting genetic testing must be justified by those proposing regulation. Our position is that the onus of justifying regulation is reversed. The risk to others whose genomic information is shared with the individual is potentially significant enough to warrant prima facie regulatory intervention, including protection against misuse of genetic information derived from those tests, not just against the individual tested but also against those who for reasons of common familial ancestry are also susceptible to misuse. Testing an individual’s genome does not merely reveal information about that individual; it reveals, or renders reasonably inferable, information about the genomes of close relatives due to the commonality of genomic DNA within families.

UR - http://www.scopus.com/inward/record.url?scp=85049151921&partnerID=8YFLogxK

U2 - 10.1136/medethics-2017-104445

DO - 10.1136/medethics-2017-104445

M3 - Comment/debate

VL - 44

SP - 791

EP - 792

JO - Journal of Medical Ethics

JF - Journal of Medical Ethics

SN - 0306-6800

IS - 11

ER -